缓慢进展型1型糖尿病的最新进展
Update on slowly progressive type 1 diabetes.
作者信息
Oikawa Yoichi, Haisa Akifumi, Satomura Atsushi, Shimada Akira
机构信息
Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
出版信息
J Diabetes Investig. 2025 Jun;16(6):989-991. doi: 10.1111/jdi.70046. Epub 2025 Apr 9.
Abstract
Slowly progressive type 1 diabetes (SPIDDM) is a subtype of type 1 diabetes in which endogenous insulin secretion gradually declines over time, eventually leading to a state of insulin dependence. The diagnostic criteria for SPIDDM were revised in Japan in 2023, with more strict guidelines. In addition, a statement regarding therapeutic interventions for suspected SPIDDM cases has been issued.
摘要
缓慢进展型1型糖尿病（SPIDDM）是1型糖尿病的一种亚型，其内生胰岛素分泌随时间逐渐下降，最终导致胰岛素依赖状态。2023年日本修订了SPIDDM的诊断标准，采用了更严格的指南。此外，还发布了一份关于疑似SPIDDM病例治疗干预的声明。
相似文献
1
Update on slowly progressive type 1 diabetes.
J Diabetes Investig. 2025 Jun;16(6):989-991. doi: 10.1111/jdi.70046. Epub 2025 Apr 9.
2
Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset.
Diabetologia. 2009 Dec;52(12):2513-21. doi: 10.1007/s00125-009-1539-9. Epub 2009 Oct 8.
3
Slowly progressive subtype of childhood-onset type 1 diabetes as a high-risk factor for end-stage renal disease: A cohort study in Japan.
J Diabetes Complications. 2025 Jan;39(1):108922. doi: 10.1016/j.jdiacomp.2024.108922. Epub 2024 Nov 28.
4
Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
Diabetologia. 1998 Aug;41(8):891-7. doi: 10.1007/s001250051004.
5
Relation between the insulin lowering rate and changes in bone mineral density: Analysis among subtypes of type 1 diabetes mellitus.
J Diabetes Investig. 2022 Sep;13(9):1585-1595. doi: 10.1111/jdi.13817. Epub 2022 May 31.
6
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version).
Diabetol Int. 2024 Jan 8;15(1):1-4. doi: 10.1007/s13340-023-00679-1. eCollection 2024 Jan.
7
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version).
J Diabetes Investig. 2024 Feb;15(2):254-257. doi: 10.1111/jdi.14121. Epub 2024 Jan 7.
8
Analysis of pancreatic volume in acute-onset, slowly-progressive and fulminant type 1 diabetes in a Japanese population.
J Diabetes Investig. 2018 Sep;9(5):1091-1099. doi: 10.1111/jdi.12816. Epub 2018 Mar 13.
9
Pioglitazone might prevent the progression of slowly progressive type 1 diabetes.
Intern Med. 2009;48(12):1037-9. doi: 10.2169/internalmedicine.48.1990. Epub 2009 Jun 15.
10
Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English Version).
Diabetol Int. 2024 Nov 12;16(1):1-6. doi: 10.1007/s13340-024-00753-2. eCollection 2025 Jan.
本文引用的文献
1
Clinical features among adult-onset type 1 diabetes, distribution of subtypes, and differences in probable and definite slowly progressive insulin-dependent diabetes mellitus: A single hospital-based study over a 13-year period.
J Diabetes Investig. 2025 May;16(5):952-958. doi: 10.1111/jdi.70012. Epub 2025 Mar 7.
2
Immune checkpoint inhibitor-related type 1 diabetes incidence, risk, and survival association.
J Diabetes Investig. 2025 Feb;16(2):334-342. doi: 10.1111/jdi.14362. Epub 2024 Nov 21.
3
Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English version).
J Diabetes Investig. 2025 Jan;16(1):163-168. doi: 10.1111/jdi.14267. Epub 2024 Nov 12.
4
High glutamic acid decarboxylase antibody titers may be associated with a decline in β-cell function over time and future insulin deficiency in latent autoimmune diabetes in adults.
Diabetes Res Clin Pract. 2024 Sep;215:111799. doi: 10.1016/j.diabres.2024.111799. Epub 2024 Jul 30.
5
Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes.
J Diabetes Investig. 2024 Jul;15(7):835-842. doi: 10.1111/jdi.14178. Epub 2024 Mar 7.
6
Fulminant type 1 diabetes, an underrecognized and unique subtype of type 1 diabetes: A case series from Singapore.
J Diabetes Investig. 2024 Jun;15(6):786-789. doi: 10.1111/jdi.14160. Epub 2024 Mar 5.
7
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version).
J Diabetes Investig. 2024 Feb;15(2):254-257. doi: 10.1111/jdi.14121. Epub 2024 Jan 7.
8
Bi-glandular and persistent enterovirus infection and distinct changes of the pancreas in slowly progressive type 1 diabetes mellitus.
Sci Rep. 2023 Apr 28;13(1):6977. doi: 10.1038/s41598-023-33011-7.
9
Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes.
J Diabetes Investig. 2023 Apr;14(4):570-581. doi: 10.1111/jdi.13980. Epub 2023 Jan 23.
10
Comparing the clinical significance and antigen specificity of insulinoma-associated antigen-2 autoantibodies between radioimmunoassay and enzyme-linked immunosorbent assay in Japanese patients with type 1 diabetes.
J Diabetes Investig. 2023 Jan;14(1):58-66. doi: 10.1111/jdi.13910. Epub 2022 Sep 30.
Zotero 插件